Literature DB >> 13130391

Memory function and brain glucose metabolism.

S Hoyer1.   

Abstract

Memory formation and memory retrieval are subject to complex cellular and molecular processes. Increasing evidence exists that neuronal glucose metabolism and its control by the insulin signal transduction cascade are the main players in such processes. Acetylcholine synthesis depends on the availability of acetyl CoA, provided from glucose breakdown, and insulin, which controls the activity of acetylcholine transferase. ATP is necessary for both synaptic activity and plasticity. This is also true for APPs, the secreted derivative of APP. Trafficking of the latter protein is controlled by insulin and insulin receptor function also acting on activity-regulated cytoskeleton-associated gene expression, which induces biochemical stimuli involved in synaptic activity and plasticity. Any damage in neuronal glucose metabolism and its control may, therefore, cause disturbances in memory function--as is found for example in sporadic Alzheimer's disease. Mimicking these metabolic and behavioral abnormalities in experimental animals, it was found that EGb 761 (definition see editorial) shows beneficial effects both on brain glucose and energy metabolism and on behavior.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13130391     DOI: 10.1055/s-2003-40452

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  18 in total

Review 1.  The Essential Role of Soluble Aβ Oligomers in Alzheimer's Disease.

Authors:  Zi-Xuan Wang; Lan Tan; Jinyuan Liu; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2015-04-02       Impact factor: 5.590

2.  Interaction of insulin and PPAR-α genes in Alzheimer's disease: the Epistasis Project.

Authors:  Heike Kölsch; Donald J Lehmann; Carla A Ibrahim-Verbaas; Onofre Combarros; Cornelia M van Duijn; Naomi Hammond; Olivia Belbin; Mario Cortina-Borja; Michael G Lehmann; Yurii S Aulchenko; Maaike Schuur; Monique Breteler; Gordon K Wilcock; Kristelle Brown; Patrick G Kehoe; Rachel Barber; Eliecer Coto; Victoria Alvarez; Panos Deloukas; Ignacio Mateo; Wolfgang Maier; Kevin Morgan; Donald R Warden; A David Smith; Reinhard Heun
Journal:  J Neural Transm (Vienna)       Date:  2011-11-08       Impact factor: 3.575

3.  N-PEP-12--a novel peptide compound that protects cortical neurons in culture against different age and disease associated lesions.

Authors:  M Windisch; B Hutter-Paier; E Grygar; E Doppler; H Moessler
Journal:  J Neural Transm (Vienna)       Date:  2005-03-07       Impact factor: 3.575

Review 4.  GluT4: A central player in hippocampal memory and brain insulin resistance.

Authors:  Ewan C McNay; Jiah Pearson-Leary
Journal:  Exp Neurol       Date:  2019-10-12       Impact factor: 5.330

5.  Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of age.

Authors:  Rukhsana Sultana; Renã A S Robinson; Fabio Di Domenico; Hafiz Mohmmad Abdul; Daret K St Clair; William R Markesbery; Jian Cai; William M Pierce; D Allan Butterfield
Journal:  J Proteomics       Date:  2011-06-25       Impact factor: 4.044

6.  Brain insulin resistance and altered brain glucose are related to memory impairments in schizophrenia.

Authors:  S Andrea Wijtenburg; Dimitrios Kapogiannis; Stephanie A Korenic; Roger J Mullins; Joyce Tran; Frank E Gaston; Shuo Chen; Maja Mustapic; L Elliot Hong; Laura M Rowland
Journal:  Schizophr Res       Date:  2019-02-11       Impact factor: 4.939

7.  Novel Roles for the Insulin-Regulated Glucose Transporter-4 in Hippocampally Dependent Memory.

Authors:  Jiah Pearson-Leary; Ewan C McNay
Journal:  J Neurosci       Date:  2016-11-23       Impact factor: 6.167

Review 8.  Mechanisms of action of brain insulin against neurodegenerative diseases.

Authors:  Mahesh Ramalingam; Sung-Jin Kim
Journal:  J Neural Transm (Vienna)       Date:  2014-01-09       Impact factor: 3.575

9.  Insulin signaling in sporadic Alzheimer's disease.

Authors:  Francesca-Fang Liao; Huaxi Xu
Journal:  Sci Signal       Date:  2009-06-09       Impact factor: 8.192

10.  Impaired cognition and attention in adults: pharmacological management strategies.

Authors:  Hervé Allain; Yvette Akwa; Lucette Lacomblez; Alain Lieury; Danièle Bentué-Ferrer
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.